Avidity coordinates with national laboratories to enhance research capabilities. We work with government researchers who conduct research to address gaps and needs in biodefense. These federal agencies provide characterization and analysis of potentially dangerous pathogens that could pose a threat.
Facilities that do this kind of research are able to develop new vaccines and diagnostic tests to respond to and control disease outbreaks. These projects that are more ambitious and riskier than standard peer-reviewed research. With these types of projects, it can help accelerate key breakthroughs without some of the restrictions that such work typically faces.